Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dxp Enterprises (DXPE) Asset Writedowns and Impairment (2016 - 2025)

Dxp Enterprises' Asset Writedowns and Impairment history spans 13 years, with the latest figure at $146000.0 for Q4 2025.

  • For Q4 2025, Asset Writedowns and Impairment rose 240.38% year-over-year to $146000.0; the TTM value through Dec 2025 reached $220000.0, up 124.8%, while the annual FY2025 figure was $220000.0, 124.8% up from the prior year.
  • Asset Writedowns and Impairment for Q4 2025 was $146000.0 at Dxp Enterprises, down from $1.2 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $1.2 million in Q3 2025 and bottomed at -$1.3 million in Q1 2025.
  • The 5-year median for Asset Writedowns and Impairment is $95500.0 (2021), against an average of -$41300.0.
  • The largest annual shift saw Asset Writedowns and Impairment plummeted 2535.71% in 2021 before it skyrocketed 9758.33% in 2025.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $428000.0 in 2021, then plummeted by 140.89% to -$175000.0 in 2022, then tumbled by 247.43% to -$608000.0 in 2023, then skyrocketed by 82.89% to -$104000.0 in 2024, then soared by 240.38% to $146000.0 in 2025.
  • Per Business Quant, the three most recent readings for DXPE's Asset Writedowns and Impairment are $146000.0 (Q4 2025), $1.2 million (Q3 2025), and $237000.0 (Q2 2025).